指南与共识前列腺增生与排尿功能障碍小儿泌尿与泌尿修复

欧洲泌尿外科学会与欧洲泌尿妇科学会关于植入材料治疗盆腔器官脱垂和压力性尿失禁的共识声明

Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence.
指南 / 共识 · Eur Urol · 2017-04-14

该共识由欧洲泌尿外科学会(EAU)与欧洲泌尿妇科学会召集共识小组,基于已发表的荟萃分析和综述,探讨聚丙烯材料治疗压力性尿失禁(SUI)和盆腔器官脱垂(POP)的现有证据。结论认为合成中段尿道吊带治疗男女SUI疗效好且并发症可接受,而合成网片用于POP仅限同一腔室复发性脱垂的复杂病例,并须由受训医生在多学科转诊中心实施。

要点

  • 合成中段尿道吊带治疗男女压力性尿失禁疗效好且并发症可接受。
  • 合成网片治疗盆腔器官脱垂仅限同一腔室复发性脱垂的复杂病例。
  • 网片手术须由受训医生在多学科转诊中心实施,患者应知晓替代疗法与风险。

核心结论

  • 合成中段尿道吊带(MUS)使用聚丙烯吊带治疗男女压力性尿失禁疗效好且并发症可接受。
  • 合成网片治疗盆腔器官脱垂应仅用于同一腔室复发性脱垂的复杂病例,并限于在多学科转诊中心工作、经过适当培训的医生。

研究设计与样本

  • 由欧洲泌尿外科学会(EAU)与欧洲泌尿妇科学会召集的共识小组会议,基于已发表的荟萃分析和综述对现有数据进行共识审查。
  • 证据参照2016年EAU指南、欧洲委员会SCENIHR手术网片报告(SCENIHR 2015)及其他高质量证据、指南和国家建议。

主要发现

  • 当前数据提示,非自体耐久材料在手术中使用具有明确确立的获益,但也存在显著风险,风险因使用条件和部位而异。
  • 已描述多种移植物相关并发症,如感染、包括性交痛在内的慢性疼痛、阴道内暴露、皱缩、异种移植物侵蚀至其他器官,以及合成聚丙烯吊带(用于SUI)和网片(用于POP)相关并发症,与腹壁疝所见并发症不同。

关键数值与推荐

  • 考虑SUI手术时,必须评估可选方案,可能包括使用聚丙烯吊带的合成中段尿道吊带(MUS)、填充剂、阴道悬吊术和自体吊带手术。
  • 合成MUS用于男女SUI手术治疗疗效好且并发症可接受。
  • 合成网片用于POP应仅用于同一腔室复发性脱垂的复杂病例,并限于在多学科转诊中心工作、经过适当培训的医生。

临床怎么用

  • 合成吊带可安全用于男女压力性尿失禁的手术治疗。
  • 患者需要了解替代疗法以及该疗法的潜在风险和并发症。
  • 治疗脱垂的合成网片应仅用于专科转诊中心的复发性脱垂复杂病例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Surgical nonautologous meshes have been used for several decades to repair abdominal wall herniae. Implantable materials have been adopted for the treatment of female and male stress urinary incontinence (SUI) and female pelvic organ prolapse (POP). OBJECTIVE: A consensus review of existing data based on published meta-analyses and reviews. EVIDENCE ACQUISITION: This document summarises the deliberations of a consensus group meeting convened by the European Association of Urology (EAU) and the European Urogynecological Association, to explore the current evidence relating to the use of polypropylene (PP) materials used for the treatment of SUI and POP, with reference to the 2016 EAU guidelines (European Association of Urology 2016), the European Commission's SCENIHR report on the use of surgical meshes (SCENIHR 2015), other available high-quality evidence, guidelines, and national recommendations. EVIDENCE SYNTHESIS: Current data suggest that the use of nonautologous durable materials in surgery has well-established benefits but significant risks, which are specific to the condition and location they are used for. Various graft-related complications have been described-such as infection, chronic pain including dyspareunia, exposure in the vagina, shrinkage, erosion into other organs of xenografts, synthetic PP tapes (used in SUI), and meshes (used in POP)-which differ from the complications seen with abdominal herniae. CONCLUSIONS: When considering surgery for SUI, it is essential to evaluate the available options, which may include synthetic midurethral slings (MUSs) using PP tapes, bulking agents, colposuspension, and autologous sling surgery. The use of synthetic MUSs for surgical treatment of SUI in both male and female patients has good efficacy and acceptable morbidity. Synthetic mesh for POP should be used only in complex cases with recurrent prolapse in the same compartment and restricted to those surgeons with appropriate training who are working in multidisciplinary referral centres. PATIENT SUMMARY: Synthetic slings can be safely used in the surgical treatment of stress incontinence in both male and female patients. Patients need to be aware of the alternative therapy and potential risks and complications of this therapy. Synthetic mesh for treating prolapse should be used only in complex cases with recurrent prolapse in specialist referral centres.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Chapple CR, Cruz F, Deffieux X, et al. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol. 2017. PMID: 28413126. doi:10.1016/j.eururo.2017.03.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。